Fluoride-assisted liquid chromatography-tandem mass spectrometry method for simultaneous analysis of propofol and its metabolites without derivatization in urine

Quantitation of propofol metabolites by LC-MS/MS demonstrating long detection window for urine drug monitoring

Introduction

Chromatographic methods for analysis of propofol and its metabolites have been widely used in pharmacokinetic studies of propofol distribution, metabolism, and clearance. Application of chromatographic methods is also needed in clinical and forensic laboratories for detecting and monitoring propofol misuse.

Objective

We report a method for sensitive analysis of propofol, propofol 1-glucuronide (PG), 4-hydroxypropofol 1-glucuronide (1-QG), 4-hydroxypropofol 4-glucuronide (4-QG) and 4-hydroxypropofol 4-sulfate (4-QS) in urine by LC-MS/MS analysis. The method employs a simple dilute-and-analyze sample preparation with stable isotope internal standardization.

Results

Validation studies demonstrate a linear calibration model (100-10,000 ng/mL), with dilution integrity verified for the extended range of concentrations experienced in propofol use. Criteria-based validation was achieved, including an average coefficient of variation of 6.5 % and a percent bias of -4.2 ng/mL. The method was evaluated in 12 surgical patients, with monitoring periods lasting up to 30 days following intravenous propofol administrations of 100-3000 mg on the day of surgery. While the concentration ratio of PG to 4-hydroxy propofol metabolite decreased significantly in the days following surgery, PG maintained the highest concentration in all specimens. Both PG and 1-QG were detectable throughout the monitoring periods, including in a patient monitored for 30 days. Lower concentrations were determined for 4-QG and 4-QS, with evidence of detection up to 20 days. Propofol was not detectable in any urine specimens, thereby proving ineffective for identifying drug use.

Conclusion

The validated method for quantifying propofol metabolites demonstrates its applicability for the sensitive detection of propofol misuse over a long window of drug-use detection.

High-Throughput Quantitative LC-MS/MS Analysis of Barbiturates in Human Urine

We hereby present a fast, high-throughput, and clinical LC-MS/MS assay for the simultaneous analysis of barbiturates in human urine. It is deployed as a quantitative assay for phenobarbital, butalbital, pentobarbital/amobarbital, and secobarbital, as well as for confirmations following positive immunoassay drug screens in patient urine. Briefly, urine specimens are processed via dilute and shoot, i.e., by mixing the sample with 20 times volume of internal standard reagent and injecting 50 μL of that mixture into the analytical instrument. Chromatographic separation is performed using a reversed-phase C18 column in a mobile-phase system doped with <1 mM ammonium fluoride. Mass spectrometric detection occurs via negative-mode electrospray ionization multiple reaction monitoring in the TSQ Quantiva triple-quadrupole instrument. All the analytes in the mixture are detected and quantified simultaneously with respect to internal calibration in the range 20-2500 ng/mL. However, the assay cannot distinguish pentobarbital from amobarbital, which are isobaric analytes. Nonetheless, the assay is sensitive, robust, and amenable to harmonization with other assays that employ barbiturate cutoffs in the range of 20-150 ng/mL.

Dynamic headspace solid-phase extraction at room temperature: a theoretical model, method, and application for propofol analysis

Herein, a simple dynamic headspace solid-phase extraction (DHS-SPE) process at room temperature was used for a material that is sensitive to increase in the temperature. A proposed method was implemented to rapidly extract propofol (PF) from a complex matrix before fluorescence spectroscopy analysis, within a short sampling time without involving a hot plate or stirrer. A mini diaphragm pump was used to circulate the headspace gas. As the headspace gas flows over the sample solution surface, bubbles form and release analytes from the liquid into the headspace. During the extraction process, the headspace gas passes through the coated metal foam as a sorbent that is placed in a homemade glass vessel and analytes are trapped from the gas phase. A theoretical model of DHS-SPE based on the consecutive first-order process is proposed in this study. A mathematical solution for the dynamic process of mass transfer was obtained by correlating the variation in analyte concentration in the headspace and adsorber with the pump speed and amount of analyte extracted to the solid phase. Using electrochemically Nafion-doped polypyrrole (PPy-Naf) film on nickel foam as the solid-phase coupled to fluorescence detection, a linear dynamic range over the concentration range of 100-500 nM with a detection limit of 15 nM was obtained. This method was applied successfully for PF determination in human serum sample matrices without the interference of co-administered drugs, such as cisatracurium, which have significant emission spectrum overlap. The developed method can lead to a new idea for sample pretreatment, which is compatible with many analytical techniques and has been successfully combined with fluorescence spectroscopy in this work. This format of sampling simplifies the transfer of analytes from complex matrices to the headspace for the extraction and preconcentration process, eliminating the heating step and the need for expensive equipment.

A simple method for simultaneous determination of organophosphate esters and their diester metabolites in dairy products and human milk by using solid-phase extraction coupled to liquid chromatography-tandem mass spectrometry

Organophosphate esters (OPEs) and their diester metabolites have been frequently found in various environmental matrices and regarded as emerging environmental pollutants, whereas data on their occurrence in foods and human matrices are still limited. In this study, a novel and simple procedure was developed to simultaneously determine 14 OPEs and 6 diester metabolites in dairy products and human milk. After enzymatic hydrolysis by β-glucuronidase/arylsulfatase, a freeze-dried milk sample was extracted with acetonitrile and purified by solid-phase extraction. Subsequently, all target compounds were determined by HPLC-ESI-MS/MS. Linearity, limits of detection (LODs), recovery, precision, and matrix effects of the proposed methodology were validated, and the parameters of HPLC-ESI-MS/MS were optimized. LODs for OPEs and their diester metabolites were from 0.001 to 0.02 ng/mL, and limits of quantification (LOQs) were 0.01-0.3 ng/mL. Average recoveries at two spiked levels ranged between 67.3 and 121%, with relative standard deviation lower than 20.7%. A test for matrix effects showed that most analytes presented signal suppression, and isotopically labeled ISs were essential for compensating for the matrix effects. Finally, OPEs and their metabolites both showed high detecting frequencies in real samples, which indicated that these emerging pollutants were ubiquitous in foods and the human body, and the impact of the diester metabolites on population exposure must be included in exposure assessment.